Announcements

Chris Siu, Chief Financial Officer of Aehr Test Systems, filed a Form 4 on September 1, 2026, reporting the disposition of 496 shares of common stock to satisfy tax withholding obligations upon the vesting of restricted stock units and restricted shares.

A Form 4 filed on September 1, 2026, discloses that Richard D. Gebert, a director of Independence Realty Trust, Inc., sold 500 shares of common stock on that same date under a pre-established Rule 10b5-1 trading plan.

Rachel Barthelemy Marcon, President of Doors at Owens Corning, filed a Form 4 on September 1, 2026, disclosing a sale of 900 shares of Owens Corning common stock on August 28, 2026, pursuant to a Rule 10b5-1 trading plan.

Albert Bourla, Chairman and CEO of Pfizer Inc., filed a Form 4 with the SEC on September 1, 2026, disclosing the acquisition of 21 Phantom Stock Units under the company's Nonfunded Deferred Compensation and Supplemental Savings Plan, with a transaction date of August 31, …

Director David B. Juran filed a Form 4 with the SEC on September 1, 2026, reporting the sale of 518 shares of Bridgewater Bancshares Inc common stock on August 28, 2026.

Director Jeffrey D. Shellberg of Bridgewater Bancshares Inc filed a Form 4 on September 1, 2026, disclosing stock option exercises and a tax-related share disposition that occurred on August 31, 2026.

Director Lucas E. Watson filed a Form 4 with the SEC on September 1, 2026, disclosing the acquisition of deferred stock units in W.W. Grainger, Inc. (NYSE:GWW) and reporting his current beneficial ownership positions.